KR870700354A - 기포성 아세틸살리실산 정제의 개선 - Google Patents

기포성 아세틸살리실산 정제의 개선

Info

Publication number
KR870700354A
KR870700354A KR870700505A KR870700505A KR870700354A KR 870700354 A KR870700354 A KR 870700354A KR 870700505 A KR870700505 A KR 870700505A KR 870700505 A KR870700505 A KR 870700505A KR 870700354 A KR870700354 A KR 870700354A
Authority
KR
South Korea
Prior art keywords
sucrose
dextrose
tablet
dry powder
powder mixture
Prior art date
Application number
KR870700505A
Other languages
English (en)
Other versions
KR940000007B1 (ko
Inventor
케이스 존스 스테펜
데이비드 윌슨 피터
Original Assignee
원본미기재
니콜라스 키위(퍼시픽) 피티와이 리미티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 원본미기재, 니콜라스 키위(퍼시픽) 피티와이 리미티드 filed Critical 원본미기재
Publication of KR870700354A publication Critical patent/KR870700354A/ko
Application granted granted Critical
Publication of KR940000007B1 publication Critical patent/KR940000007B1/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

내용 없음

Description

기포성 아세틸살리실산 정제의 개선
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (12)

  1. 건조분말 혼합물을 직접 압착시켜 수득한 기포성 아세틸살리실산 정제에 있어서 붕해제 및 또는 용해 보조제로서의 분말상 덱스트로즈 및 또는 슈크로즈의 용도.
  2. 건조분말 혼합물중에 분말상 덱스트로즈 및 또는 슈크로즈를 혼합시킴을 특징으로하여, 상기 혼합물을 지접 압착시켜 수득한 기포성 아세틸살리실산 정제의 붕해 및 용해 속도를 증가시키는 방법.
  3. 직접 압착된 건조분말 혼합물과 비교하여 정제의 붕해 및 또는 용해 속도를 증가 시키기에 충분한 양의 분말상 덱스트로즈 및 또는 슈크로즈와 혼합한 직접 압착가능한 건조분말 혼합물을 직접 압착시켜 수득한 기포성 아세틸살리실산 정제.
  4. 제 3 항에 있어서,
    덱스트로즈 및 또는 슈크로즈가 건조분말 혼합물의 다른 성분의 혼합중량을 기준으로하여 10 내지 40중량%의 양으로 존재하는 정제.
  5. 제 4 항에 있어서,
    덱스트로즈 및 또는 슈크로즈의 양이 건조분말 혼합물의 다른 성분의 혼합중량을 기준으로하여 15내지 30중량%인 정제.
  6. 제 3 항에 있어서,
    덱스트로즈 및 또는 슈크로즈가 덱스트로즈인 정제.
  7. 제 6 항에 있어서,
    덱스트로즈가 덱스트레이트의 형태인 정제.
  8. 제 3 항에 있어서,
    덱스트로즈 및 슈크로즈가 분무-결정화 형태인 정제.
  9. 제 3 항에 있어서,
    건조분말 혼합물이 덱스트로즈 및 슈크로즈외에 필수적으로 아세틸살리실산, 중탄산나트륨 및 시트르산으로 이루어지는 정제.
  10. 제 3 항에 있어서.
    아세틸살리실산이 저분자량의 아미노산, 서당, 서당알코올 및 이들의 혼합물중에서 선택된 융점 105℃이상의 수용성 피복물질로 피복된 입자형태인 정제.
  11. 제 3 항에 있어서,
    기포성 커플의 염기성분이 큰 비율의 중탄산 나트륨과 적은 비율의 탄산나트륨으로 이루어진 혼합물인 정제.
  12. 제 11항에 있어서,
    염기성분이 5 내지 25중량%의 탄산 나트륨을 함유하는 정제.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019870700505A 1985-10-15 1986-10-14 개선된 아세틸살리실산 비등정의 제조방법 KR940000007B1 (ko)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB8525348 1985-10-15
GB858525348A GB8525348D0 (en) 1985-10-15 1985-10-15 Effervescent tablets
AU8525348 1985-10-15
PCT/AU1986/000304 WO1987002242A1 (en) 1985-10-15 1986-10-14 Improvements in and relating to effervescent acetylsalicylic acid tablets

Publications (2)

Publication Number Publication Date
KR870700354A true KR870700354A (ko) 1987-12-28
KR940000007B1 KR940000007B1 (ko) 1994-01-05

Family

ID=10586665

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019870700505A KR940000007B1 (ko) 1985-10-15 1986-10-14 개선된 아세틸살리실산 비등정의 제조방법

Country Status (17)

Country Link
US (1) US5037657A (ko)
EP (1) EP0219337A3 (ko)
JP (1) JPH078797B2 (ko)
KR (1) KR940000007B1 (ko)
AU (1) AU600687B2 (ko)
CA (1) CA1275252C (ko)
DK (1) DK302087A (ko)
FI (1) FI872638A0 (ko)
GB (2) GB8525348D0 (ko)
HK (1) HK37890A (ko)
MA (1) MA20794A1 (ko)
MY (1) MY102728A (ko)
NZ (1) NZ217909A (ko)
PH (1) PH25418A (ko)
PT (1) PT83541B (ko)
WO (1) WO1987002242A1 (ko)
ZA (1) ZA867816B (ko)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ232346A (en) * 1989-02-07 1992-03-26 Duphar Int Res Effervescent oral rehydration solution comprising saccharides, amino acids and bicarbonate salts
JP2523384B2 (ja) * 1990-02-02 1996-08-07 エスエス製薬株式会社 発泡性製剤組成物
US5223264A (en) * 1989-10-02 1993-06-29 Cima Labs, Inc. Pediatric effervescent dosage form
ATE145551T1 (de) * 1989-10-02 1996-12-15 Cima Labs Inc Brausedosisform sowie verfahren zu deren verabreichung
US5064656A (en) * 1989-11-14 1991-11-12 Dr. Gergely & Co. Uncoated pharmaceutical reaction tablet
US5770319A (en) * 1990-08-23 1998-06-23 Her Majesty The Queen In Right Of New Zealand Densification of lignocellulosic material
DE4027927A1 (de) * 1990-09-04 1992-03-05 Bayer Ag Brausekomponente und verfahren zu ihrer herstellung
ATE128027T1 (de) * 1991-07-01 1995-10-15 Gergely Gerhard Lutsch- oder kautablette.
GB9203689D0 (en) * 1992-02-20 1992-04-08 Euro Celtique Sa Pharmaceutical composition
CA2128820A1 (en) * 1993-07-27 1995-01-28 Walter G. Gowan, Jr. Rapidly disintegrating pharmaceutical dosage form and process for preparation thereof
US5866162A (en) * 1993-08-10 1999-02-02 Smithkline Beecham P.L.C. Pharmaceutical composition containing a drug/β-cyclodextrin complex in combination with an acid-base couple
DE4420735C2 (de) * 1994-06-15 1996-09-05 Allphamed Arzneimittel Gmbh Verfahren zur Herstellung mechanisch stabiler, sich mit hoher Auflösegeschwindigkeit auszeichnender Brausetabletten
US5837286A (en) * 1997-01-15 1998-11-17 Pandya; Harish B. Taste masking for unplatable formulations
DE19931708A1 (de) * 1999-07-08 2001-01-18 Bayer Ag Verfahren zur Herstellung schnell zerfallender, fester pharmazeutischer Zubereitungen
ITMI20022619A1 (it) * 2002-12-11 2004-06-12 Ind Italiana Integratori Trei S P A Preparazioni farmaceutiche ad uso veterinario contenenti acido acetilsalicilico in forma di polvere solubile tamponata.
JP2011168615A (ja) * 2003-10-16 2011-09-01 Daiichi Sankyo Healthcare Co Ltd サリチル酸類含有経口組成物
BRPI0907601A2 (pt) * 2008-02-27 2019-09-24 Cadbury Adams Usa Llc artigo de doce com multi-região
CA3107412A1 (en) 2018-11-30 2020-06-04 Amerilab Technologies, Inc. Effervescent tablets that include crystalline sugar binder and methods of making the same
CN112940872A (zh) * 2019-12-11 2021-06-11 凯文果园株式会社 固体洗涤剂

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2639238A (en) * 1952-07-02 1953-05-19 Joseph G Alther Effervescent drink concentrate
US3619292A (en) * 1968-07-15 1971-11-09 Penick & Ford Ltd Tablets and method of forming
US3587596A (en) * 1969-01-13 1971-06-28 Sperry Rand Corp Manicuring attachment for electric dry shaver
BE759520A (fr) * 1969-11-28 1971-04-30 Aspro Nicholas Ltd Compositions d'aspirine
US3887700A (en) * 1969-11-28 1975-06-03 Aspro Nicholas Ltd Analgesic formulations
DE1962791A1 (de) * 1969-12-15 1971-06-24 Boehringer Mannheim Gmbh Brausetabletten,Brausepulver und Verfahren zur Herstellung derselben
GB1473315A (en) * 1974-06-10 1977-05-11 Smith W Freeze-dried flavoured pharmaceuticals
US3996355A (en) * 1975-01-02 1976-12-07 American Home Products Corporation Permanent suspension pharmaceutical dosage form
GB1505738A (en) * 1975-02-26 1978-03-30 Kirby Pharmaceuticals Ltd Tabletting processes
US4369308A (en) * 1981-07-24 1983-01-18 National Starch And Chemical Corporation Low swelling starches as tablet disintegrants
AT373492B (de) * 1981-12-14 1984-01-25 Arcana Chem Pharm Verfahren zur herstellung von brausetabletten
US4551177A (en) * 1984-04-23 1985-11-05 National Starch And Chemical Corporation Compressible starches as binders for tablets or capsules
US4650669A (en) * 1985-07-30 1987-03-17 Miles Laboratories, Inc. Method to make effervescent calcium tablets and calcium tablets produced thereby

Also Published As

Publication number Publication date
FI872638A (fi) 1987-06-12
GB8624520D0 (en) 1986-11-19
FI872638A0 (fi) 1987-06-12
EP0219337A2 (en) 1987-04-22
US5037657A (en) 1991-08-06
AU6529086A (en) 1987-05-05
DK302087D0 (da) 1987-06-12
MY102728A (en) 1992-09-30
WO1987002242A1 (en) 1987-04-23
JPH078797B2 (ja) 1995-02-01
GB8525348D0 (en) 1985-11-20
GB2189700B (en) 1989-10-18
MA20794A1 (fr) 1987-07-01
ZA867816B (en) 1987-06-24
CA1275252C (en) 1990-10-16
DK302087A (da) 1987-06-12
KR940000007B1 (ko) 1994-01-05
PT83541B (pt) 1988-11-30
AU600687B2 (en) 1990-08-23
PH25418A (en) 1991-07-01
HK37890A (en) 1990-05-25
NZ217909A (en) 1988-10-28
GB2189700A (en) 1987-11-04
EP0219337A3 (en) 1987-09-16
PT83541A (en) 1986-11-01
JPS63501505A (ja) 1988-06-09

Similar Documents

Publication Publication Date Title
KR870700354A (ko) 기포성 아세틸살리실산 정제의 개선
KR850007559A (ko) 조절 펩타이드의 삽입식 제형
ES2064112T3 (es) Composicion farmaceutica para suspension rapida en agua.
ES471896A1 (es) Procedimiento para preparar particulas conteniendo enzimas
CA2009890A1 (en) Valproic acid
SE8303531D0 (sv) Farmaceutisk komposition
DE69434626D1 (de) Transparente flüssigkeit zur verabreichung von verkapselten medikamenten
DK0630192T3 (da) Psyllium-drikkeblandingsprodukter indeholdende granuleret base
NZ337418A (en) Paracetamol composition with improved rate of absorption
JPS5213599A (en) Preparation of aqueous polyurethane emulsion
GB931946A (en) Production of tablets of pharmaceutical and other chemical compositions
CA2007260A1 (en) Effervescent analgesic antacid composition having reduced sodium content (ms-1569-cip-11)
KR840004347A (ko) 불안정한 약물 또는 음식물 첨가물의 안정화
TR200401492T1 (tr) Köpük halinde bir krema (mousse)
KR870000015A (ko) 쑥차의 제조방법
LV11818A (lv) Jauna farmaceitiska kompozicija stabilas pulverveida zalu formas pagatavosanai
HUP0101822A2 (hu) Pezsegő kompozíciók és eljárás az előállításukra
ES2064465T3 (es) Composiciones detergentes que contienen enzima y su uso.
JPS53135925A (en) Decomposition of microbial cells
KR910008169A (ko) 1,1-디클로로-2,2,2-트리플루오로에탄 및 1,1-디클로로-1-플루오로에탄의 안정화된 공비 혼합물-형 조성물
JPS57102814A (en) Tablet
JPS5668619A (en) Nifedipine-containing solid composition
JPS6430563A (en) Concentrated and dried juice of plum or watermelon and preparation thereof
KR860006983A (ko) 아세틸 살리실산과 디펜하이드라민 시트레이트의 안정한 발포성 조성물의 제조방법
KR890001559A (ko) 트라피딜을 함유하는 제약 조성물, 그의 제조방법 및 관련된 치료 용도

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
NORF Unpaid initial registration fee